Publications by authors named "Gleb Makshakov"

Claim this Profile
V
Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
Evgeniy Evdoshenko, Kristina Laskova, Maria Shumilina, Ekaterina Nekrashevich, Maria Andreeva, Gleb Makshakov

J Int Neuropsychol Soc· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic evaluation of the guidelines for rehabilitation in multiple sclerosis patients: an overview according to ICF functioning domains.
Bernardita Soler, Joke Raats, Zuhal Abasiyanik, Ilse Lamers, Gleb Makshakov

Int J Rehabil Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.
Marina Kleopatra Boziki, Alexios-Fotios A Mentis, Maria Shumilina, Gleb Makshakov, Evgeniy Evdoshenko

Brain Sci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.
Evgeniy Evdoshenko, Alexandra Stepanova, Maria Shumilina, Maria Davydovskaya, Natalia Khachanova, Gleb Makshakov

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis.
Vladimir Nazarov, Gleb Makshakov, Ivan Kalinin, Sergey Lapin, Elena Surkova

Immunol Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
Clara Matute-Blanch, Luisa M Villar, José C Álvarez-Cermeño, Konrad Rejdak, Evgeniy Evdoshenko, Gleb Makshakov

Brain· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis.
Gleb Makshakov, Evgeniy Magonov, Natalia Totolyan, Vladimir Nazarov, Sergey Lapin

Neurol Res Int· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
Alexey Belogurov, Konstantin Zakharov, Yakov Lomakin, Kirill Surkov, Sergey Avtushenko, Gleb Makshakov

Neurotherapeutics· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
Gleb Makshakov, Vladimir Nazarov, Olga Kochetova, Elena Surkova, Sergey Lapin

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis